NATALIE BOHATYRITZ: Open Payments
NPI 1396518940 · BRANDON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,948 in 194 payments from 19 companies in 2025. Trend: 2023 $218 · 2024 $3,377 · 2025 $3,948
Food & beverage: $3,948
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $844 |
| Amgen Inc. | 33 | $725 |
| UCB, Inc. | 32 | $509 |
| AstraZeneca Pharmaceuticals LP | 15 | $331 |
| ANI Pharmaceuticals, Inc. | 19 | $325 |
| Novartis Pharmaceuticals Corporation | 13 | $211 |
| Mallinckrodt Hospital Products Inc. | 11 | $186 |
| Janssen Biotech, Inc. | 10 | $161 |
| GlaxoSmithKline, LLC. | 9 | $150 |
| PFIZER INC. | 7 | $138 |
Products named: RINVOQ, Bimzelx, SAPHNELO, SKYRIZI, PURIFIED CORTROPHIN GEL, EVENITY, COSENTYX, ACTHAR.
Industry payments across FL — which companies pay providers there.
